Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Conditions

Tobacco Use Disorder 1Smoking 1

Interventions

Tobacco Use Cessation Devices 2zileuton 1olaparib 1Vitamin B 12 1Varenicline 1Radiotherapy 1Patient Navigation 1Nicotine Replacement Therapy 1Folic Acid 1Erlotinib Hydrochloride 1Cycloserine 1Cetuximab 1Celecoxib 1Budesonide 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Smoking × zileuton × Clear all
NCT01021215 2015-04-02

Zileuton With or Without Celecoxib As Chemopreventive Agents in Smokers

National Cancer Institute (NCI)

Phase 1/2 Completed
84 enrolled 10 charts

Smoking, Tobacco Use Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡